DZ Bank’s La Jolla Pharmaceutical Company LJPC Stock Holding History

DZ Bank’s Portfolio LJPC Stock Details LJPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-109,261	Closed	-$3.25M	–	1214
2018 Q1	$3.25M	Buy	+109,261	New	+$3.52M	0.01%	467

Other funds holding LJPC

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

DZ Bank's LJPC Position: Q2 2018 in Review

DZ Bank sold out of La Jolla Pharmaceutical Company (LJPC) in Q2 2018, closing a stake of 109,261 shares — an estimated $3.25M sold.

DZ Bank first reported a position in LJPC in Q1 2018 and held it in 1 quarter. The position peaked at $3.25M in Q1 2018. 95 funds tracked by Wall St. Rank hold LJPC as of Q2 2018.

DZ Bank reported no remaining La Jolla Pharmaceutical Company position as of Q2 2018 after selling out during the quarter.
DZ Bank sold 109,261 La Jolla Pharmaceutical Company shares in Q2 2018, an estimated $3.25M.
DZ Bank first reported a position in La Jolla Pharmaceutical Company in Q1 2018 and held it in 1 quarter.
DZ Bank's La Jolla Pharmaceutical Company position peaked at $3.25M in Q1 2018.
95 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2018.

Based on DZ Bank's 13F filing for Q2 2018, filed 14 Aug 2018.